Welcome to our dedicated page for Cartesian Growth II-A SEC filings (Ticker: RENEF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Cartesian Growth II-A's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Cartesian Growth II-A's regulatory disclosures and financial reporting.
Cartesian Growth Corporation is a Cayman Islands-based blank check company formed to complete an initial business combination. It raised $230 million in its May 2022 IPO of 23,000,000 units and placed $236.9 million into a trust account.
Shareholders have repeatedly extended the deadline to complete a deal, now pushed to August 5, 2026, and have redeemed large blocks of shares. Redemptions tied to three charter extensions totaled over $228 million, reducing the trust balance to about $37.8 million.
On May 6, 2025, Nasdaq determined the company no longer complied with SPAC listing Rule IM-5101-2 after it failed to complete a business combination within 36 months. Its securities were delisted and now trade on the OTC Pink Limited Market. As of March 31, 2026, 8,826,092 Class A ordinary shares and two Class B ordinary shares were outstanding. The company highlights extensive risks typical of SPACs, including deal uncertainty, heavy redemption risk, possible need for additional financing and the prospect of liquidation if no transaction is completed by the Extended Date.
MMCAP International Inc. SPC and Asset Management Inc. report a 9.1% beneficial ownership stake in Cartesian Growth Corporation II’s Class A ordinary shares. They jointly hold 800,000 shares with shared voting and dispositive power and no sole authority over any shares.
The firms certify the holdings were not acquired to change or influence control of the company and are not part of any control-related transaction. This amended Schedule 13G reflects their status as passive investors in Cartesian Growth Corporation II as of December 31, 2025.
Mizuho Financial Group, Inc. has filed an amended Schedule 13G reporting beneficial ownership of 159,400 Cartesian Growth Corporation II common shares, representing 1.2% of the class as of December 31, 2025. Mizuho has sole voting and sole dispositive power over all reported shares.
The filing notes that Mizuho Financial Group, Mizuho Bank, Ltd. and Mizuho Americas LLC may be deemed indirect beneficial owners of equity securities directly held by their wholly owned subsidiary, Mizuho Securities USA LLC. The holding is below 5% of the outstanding class and is certified as being held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Cartesian Growth Corporation II (REEUF) filed its quarterly report. The SPAC reported cash and marketable securities in its Trust Account of $88,478,622 as of September 30, 2025, with cash of $44,123 outside the trust and a working capital deficit of $5,298,431. Net income was $338,160 for the quarter and $745,793 year-to-date, driven primarily by interest income on trust assets.
Shareholders redeemed 8,620,849 Class A shares for approximately $99,613,642 at $11.55 per share in connection with the November 2024 charter extension, leaving $83,770,196.61 in the Trust at that time. The company extended its combination deadline monthly to November 10, 2025 via sponsor-funded promissory notes, including $2.4 million available under a Second Extension Note, with $1.5 million of $250,000 monthly payments approved from May to October 2025.
Management disclosed “substantial doubt” about the company’s ability to continue as a going concern due to liquidity and the looming deadline. On July 15, 2025, its securities were delisted from Nasdaq and are now quoted on the OTC Pink. As of November 13, 2025, there were 8,826,092 Class A shares and two Class B shares outstanding.
MMCAP International Inc. SPC and MM Asset Management Inc. filed a Schedule 13G reporting passive beneficial ownership of 800,000 Class A Ordinary Shares of Cartesian Growth Corporation II, representing 6.2% of the class.
The reporting persons have shared voting and dispositive power over 800,000 shares and no sole voting or dispositive power. The stated percentage is based on 12,999,710 shares outstanding as of August 6, 2025. The date of event requiring this filing is November 4, 2025. They certified the holdings were not acquired to change or influence control of the issuer.
Context Capital Management, LLC and affiliates filed a Schedule 13G reporting beneficial ownership of 450,000 Class A Ordinary Shares of Cartesian Growth Corp II, representing 5.1% of the class.
The filers report shared voting and dispositive power over 450,000 shares and no sole power. The percentage is based on 8,826,092 shares outstanding as of November 3, 2025, as disclosed by the issuer following redemptions. The LP holds the shares for the benefit of its investors. The filing states the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control. The reporting persons file jointly, disclaim group membership, and each disclaims beneficial ownership beyond their pecuniary interest.
Cartesian Growth Corporation II reported shareholder approval of an amendment to extend its deadline to complete an initial business combination from November 5, 2025 to August 5, 2026. The measure passed at an extraordinary general meeting with 8,863,937 votes for and 3,155,321 against.
In connection with the vote, holders redeemed 4,173,618 Class A ordinary shares at approximately $12.27 per share. On the October 10, 2025 record date, 12,999,712 ordinary shares were outstanding, and approximately 92.458% were represented at the meeting.
Cartesian Growth Corporation II called an Extraordinary General Meeting on November 3, 2025, to vote on extending its deadline to complete an initial business combination from November 5, 2025 to August 5, 2026 and, if needed, to adjourn the meeting to solicit more votes.
Public shareholders may elect to redeem their Class A ordinary shares for cash equal to the funds in the trust account divided by outstanding public shares. Based on the trust balance as of October 17, 2025, the anticipated per‑share redemption price is approximately $12.24. The deadline to submit redemption requests and deliver shares is 5:00 p.m. ET on October 30, 2025. Warrants have no redemption rights and would expire worthless if the company winds up.
The extension requires a Cayman Islands special resolution: at least two‑thirds of votes cast by holders of Class A and Class B shares voting together. The adjournment proposal requires a simple majority of votes cast. The record date is October 10, 2025, with 12,999,712 ordinary shares outstanding (12,999,710 Class A and 2 Class B). If the extension is approved, the company plans a later shareholder vote on a business combination.
Cartesian Growth Corporation II announced it entered into a non-binding Letter of Framework with PLXSUR Limited outlining terms for a potential business combination. The framework memorializes progress and shared objectives but does not obligate either party to proceed.
The company states there is no guarantee it will enter a definitive agreement with PLXSUR or close a transaction by its termination date, which may be extended. Any transaction would require board and stakeholder approvals for both entities, regulatory approvals, and other customary closing conditions.
The company filed a preliminary proxy statement on October 8, 2025, related to its extraordinary general meeting of shareholders, and urges investors to review it and future definitive materials when available.